ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Cancer Immunology and Immunotherapy
Latest ESMO videos
Featured medwireNews
Sacituzumab Govitecan Has ‘Encouraging’ Activity In Platinum-Ineligible, ICI-Treated Metastatic UC
MonumenTAL-1 Shows Potential Of Novel Bispecific Antibody In Pretreated Multiple Myeloma
IMMUNED Confirms OS Benefit For Nivolumab–Ipilimumab After Initial Stage IV Melanoma Treatment
Thoracic Cancer Mortality After COVID-19 Not Linked To Recent Systemic Therapy
Pembrolizumab–Etoposide Offers Long-Term ‘Clinically Meaningful Improvement’ In ES-SCLC Survival
E-Learning
ESMO E-Learning: First Line Immunotherapy for Oesophageal and Gastric Cancer as New Standard of Care
ESMO E-Learning: Metastatic Melanoma Treatment
ESMO E-Learning: Immunotherapy Strategies for Colorectal Cancer
Factsheets on Biomarkers
Tumour Mutational Load: ESMO Biomarker Factsheet
Meeting resources
ESMO Course
ESMO Preceptorship on NSCLC 2023: Singapore
Singapore
ESMO Course
ESMO Preceptorship on Immuno-Oncology 2022: Zurich, December
Zurich
ESMO Course
ESMO Preceptorship on Immuno-Oncology 2022: Singapore
Singapore
ESMO Congress
ESMO Immuno-Oncology Congress 2022
Geneva